Training cover

Replay - Overview of new 2021 ATS Clinical Practice Guidelines: Use of Fractional Exhaled Nitric Oxide (FeNO) to Guide the Treatment of Asthma


Gratuit


Vyaire Medical

4.6

· 4681 Avis

Voir le catalogue
À propos Intervenants Public cible Avis

À propos

01h00

Anglais

Asthma is a heterogenous disease. Treatment decisions are typically based on measures of airflow obstruction, the frequency of daytime and nighttime symptoms, and the frequency of exacerbations. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. The new ATS Clinical Practice Guidelines provide evidence-based clinical guidance on whether FeNO testing is indicated to optimize asthma treatment in patients with asthma in whom treatment is being considered. During this webinar, Dr. Philip Silkoff, will review, which questions about FeNO where considered by the ATS committee, the principal findings of the data review and the implication of FeNO testing for the asthma care.

Speakers icon

Intervenants

Speaker Avatar
Dr. Philip Silkoff Senior clinical trial executive
Target audience icon

Public cible

L’évènement est à destination des praticiens ou spécialités ci-dessous :

Pneumologie

Reviews icon

Les avis de vos pairs sur Vyaire Medical

Appréciation générale

5.0 · 1 Avis

Connaissances acquises

 

5.0

Organisation

 

5.0

Pédagogie

 

5.0

Recommandation

 

5.0

Contact icon

Contactez l’équipe Invivox

Discussion instantanée

- Chat disponible en bas à gauche